The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
NuCana plc(NASDAQ:NCNA)


NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients wit...
Website: http://www.nucana.com
Founded: 1997
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
NuCana plc Op Cashflow Per Share ttm
NuCana plc Free Cashflow Per Share ttm
NuCana plc Cash Per Share ttm
NuCana plc (GAAP) P/E ratio ttm
NuCana plc P/B ratio ttm
No extra charts and metrics for this ticker.